CoChat

Hepcidin is regulated by promoter-associated histone acetylation and HDAC3

Open access
Pasricha, Sant-Rayn, Lim, Pei Jin, Duarte, Tiago L., Casu, Carla, Oosterhuis, Dorenda, Mleczko-Sanecka, Katarzyna, Suciu, Maria, Da Silva, Ana Rita, Al-Hourani, Kinda, Arezes, João, McHugh, Kirsty, Gooding, Sarah, Frost, Joe N., Wray, Katherine, Santos, Ana, Porto, Graça, Repapi, Emmanouela, Gray, Nicki, Draper, Simon J., Ashley, Neil, Soilleux, Elizabeth, Olinga, Peter, Muckenthaler, Martina U., Hughes, Jim R., Rivella, Stefano, Milne, Thomas A., Armitage, Andrew E., Drakesmith, Hal · 2017 · Nature Communications
Cited by 65

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Hepcidin regulates systemic iron homeostasis. Suppression of hepcidin expression occurs physiologically in iron deficiency and increased erythropoiesis but is pathologic in thalassemia and hemochromatosis. Here we show that epigenetic events govern hepcidin expression. Erythropoiesis and iron deficiency suppress hepcidin via erythroferrone-dependent and -independent mechanisms, respectively, in vivo, but both involve reversible loss of H3K9ac and H3K4me3 at the hepcidin locus. In vitro, pan-histone deacetylase inhibition elevates hepcidin expression, and in vivo maintains H3K9ac at hepcidin-associated chromatin and abrogates hepcidin suppression by erythropoietin, iron deficiency, thalassemia, and hemochromatosis. Histone deacetylase 3 and its cofactor NCOR1 regulate hepcidin; histone deacetylase 3 binds chromatin at the hepcidin locus, and histone deacetylase 3 knockdown counteracts hepcidin suppression induced either by erythroferrone or by inhibiting bone morphogenetic protein signaling. In iron deficient mice, the histone deacetylase 3 inhibitor RGFP966 increases hepcidin, and RNA sequencing confirms hepcidin is one of the genes most differentially regulated by this drug in vivo. We conclude that suppression of hepcidin expression involves epigenetic regulation by histone deacetylase 3.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-00500-z

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 25

  1. Steinbicker, A. U. & Muckenthaler, M. U. Out of balance--systemic iron homeostasis in iron-related disorders. Nutrients 5, 3034–3061 (2013). · DOI · Paper page
  2. Ramos, E. et al. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 53, 1333–1341 (2011). · DOI · Paper page
  3. Bridle, K. R. et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669–673 (2003). · DOI · Paper page
  4. Gardenghi, S. et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 109, 5027–5035 (2007). · DOI · Paper page
  5. Camaschella, C. Treating iron overload. N. Engl. J. Med. 368, 2325–2327 (2013). · DOI · Paper page
  6. Turner, B. M. Defining an epigenetic code. Nat. Cell Biol. 9, 2–6 (2007). · DOI · Paper page
  7. Mleczko-Sanecka, K. et al. Imatinib and spironolactone suppress hepcidin expression. Haematologica 102, 1173–1184 (2017). · DOI
  8. Garnock-Jones, K. P. Panobinostat: first global approval. Drugs 75, 695–704 (2015). · DOI · Paper page
  9. Tang, Z. et al. SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53. Cell 154, 297–310 (2013). · DOI · Paper page
  10. Bishton, M. J. et al. Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia. Blood 117, 3658–3668 (2011). · DOI · Paper page
  11. Anne, M., Sammartino, D., Barginear, M. F. & Budman, D. Profile of panobinostat and its potential for treatment in solid tumors: an update. Onco Targets Ther. 6, 1613–1624 (2013). · DOI
  12. Muckenthaler, M. et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat. Genet. 34, 102–107 (2003). · DOI · Paper page
  13. Chen, K. et al. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc. Natl Acad. Sci. USA 106, 17413–17418 (2009). · DOI · Paper page
  14. de Graaf, I. A. et al. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat. Protoc. 5, 1540–1551 (2010). · DOI · Paper page
  15. Malvaez, M. et al. HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner. Proc. Natl Acad. Sci. USA 110, 2647–2652 (2013). · DOI · Paper page
  16. You, S. H. et al. Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo. Nat. Struct. Mol. Biol. 20, 182–187 (2013). · DOI · Paper page
  17. Liu, L., Lin, W., Zhang, Q., Cao, W. & Liu, Z. TGF-beta induces miR-30d down-regulation and podocyte injury through Smad2/3 and HDAC3-associated transcriptional repression. J. Mol. Med. 94, 291–300 (2016). · DOI
  18. Camaschella, C., Pagani, A., Nai, A. & Silvestri, L. The mutual control of iron and erythropoiesis. Int. J. Lab. Hematol. 38(Suppl 1), 20–26 (2016). · DOI · Paper page
  19. Kim, A. & Nemeth, E. New insights into iron regulation and erythropoiesis. Curr. Opin. Hematol. 22, 199–205 (2015). · DOI · Paper page
  20. Sun, Z. et al. Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor. Mol. Cell 52, 769–782 (2013). · DOI · Paper page
  21. Alenghat, T. et al. Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 456, 997–1000 (2008). · DOI · Paper page
  22. Bahram, S. et al. Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism. Proc. Natl Acad. Sci. USA 96, 13312–13317 (1999). · DOI · Paper page
  23. Nakabayashi, H. et al. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42, 3858–3863 (1982).
  24. Sridhar, S. et al. Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A. J. Virol. 82, 3822–3833 (2008). · DOI
  25. Douglas, A. D. et al. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat. Commun. 2, 601 (2011). · DOI · Paper page

Cited by

See all 65

Metadata

Authors
Pasricha, S.-R., Lim, P. J., Duarte, T. L., Casu, C., Oosterhuis, D., Mleczko-Sanecka, K., Suciu, M., Da Silva, A. R., Al-Hourani, K., Arezes, J., McHugh, K., Gooding, S., Frost, J. N., Wray, K., Santos, A., Porto, G., Repapi, E., Gray, N., Draper, S. J., Ashley, N., Soilleux, E., Olinga, P., Muckenthaler, M. U., Hughes, J. R., Rivella, S., Milne, T. A., Armitage, A. E., & Drakesmith, H.
Venue
Nature Communications
Published
2017-09-01
Volume
8
Issue
1
Pages
403-403
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2746508988
Cited by
65
References
30
FWCI
5.07
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepcidin is regulated by promoter-associated histone acetylation and HDAC3. https://app.cochat.ai/papers/10.1038/s41467-017-00500-z
The paper
Pasricha, S.-R., Lim, P. J., Duarte, T. L., Casu, C., Oosterhuis, D., Mleczko-Sanecka, K., Suciu, M., Da Silva, A. R., Al-Hourani, K., Arezes, J., McHugh, K., Gooding, S., Frost, J. N., Wray, K., Santos, A., Porto, G., Repapi, E., Gray, N., Draper, S. J., . . . Drakesmith, H. (2017). Hepcidin is regulated by promoter-associated histone acetylation and HDAC3. Nature Communications. https://doi.org/10.1038/s41467-017-00500-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.